Loading
AP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) Stock: price and insider trades · Canada
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation): what insiders have been doing
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) is a listed company. Its directors and officers file their transactions with SEDI. Nothing new has been filed by managers of Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) in twelve months, the latest record being from 27 December 2017.
Looking back to 2015, when coverage begins, insiders filed 42 purchases and 71 sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
122
Thresholds
n/a
Buy Volume
€422,294
42 ops. · all time
Sell Volume
€778,016
71 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 27 December 2017
Declarations122 total
27,900 shares@ CA$0.29893.5% of flowCommon SharesTSXSEDI:3105189
Canonical exit: 27 Mar 2018 (T+90)
50,000 shares@ CA$0.28656.0% of flowCommon SharesTSXSEDI:3105188
Canonical exit: 27 Mar 2018 (T+90)
Common SharesTSXSEDI:3103483
49,700 shares@ CA$0.3019.6% of flowCommon SharesTSXSEDI:3103487
Canonical exit: 18 Mar 2018 (T+90)
2,000 shares@ CA$0.1950.2% of flowCommon SharesTSXSEDI:3090274
Canonical exit: 22 Feb 2018 (T+90)
120,000 shares@ CA$0.17310.6% of flowCommon SharesTSXSEDI:3090269
Canonical exit: 21 Feb 2018 (T+90)
194,900 shares@ CA$0.2120.7% of flowCommon SharesTSXSEDI:3090279
Canonical exit: 25 Feb 2018 (T+90)
28,500 shares@ CA$0.172.5% of flowCommon SharesTSXSEDI:3090266
Canonical exit: 21 Feb 2018 (T+90)
157,000 shares@ CA$0.18614.9% of flowCommon SharesTSXSEDI:3090272
Canonical exit: 22 Feb 2018 (T+90)
16,000 shares@ CA$0.201.6% of flowCommon SharesTSXSEDI:3090276
Canonical exit: 22 Feb 2018 (T+90)
196,000 shares@ CA$0.1744.1% of flowCommon SharesTSXSEDI:3086041
Canonical exit: 19 Feb 2018 (T+90)
32,000 shares@ CA$0.177.2% of flowCommon SharesTSXSEDI:3086039
Canonical exit: 18 Feb 2018 (T+90)
5,100 shares@ CA$0.180.4% of flowCommon SharesTSXSEDI:3085184
Canonical exit: 15 Feb 2018 (T+90)
2,000 shares@ CA$0.150.1% of flowCommon SharesTSXSEDI:3085183
Canonical exit: 13 Feb 2018 (T+90)
62,000 shares@ CA$0.1411.7% of flowCommon SharesTSXSEDI:3084680
Canonical exit: 11 Feb 2018 (T+90)
9,500 shares@ CA$0.141.8% of flowCommon SharesTSXSEDI:3084684
Canonical exit: 13 Feb 2018 (T+90)
12,500 shares@ CA$0.1452.4% of flowCommon SharesTSXSEDI:3084682
Canonical exit: 12 Feb 2018 (T+90)
Common SharesTSXSEDI:3083741
33,000 shares@ CA$0.15100.0% of flowCommon SharesTSXSEDI:3083744
Canonical exit: 13 Feb 2018 (T+90)
Common SharesTSXSEDI:3082442
75,000 shares@ CA$0.1313.2% of flowCommon SharesTSXSEDI:3082444
Canonical exit: 7 Feb 2018 (T+90)
13,500 shares@ CA$0.120.7% of flowCommon SharesTSXSEDI:3082461
Canonical exit: 7 Feb 2018 (T+90)
500,000 shares@ CA$0.12526.5% of flowCommon SharesTSXSEDI:3082460
Canonical exit: 7 Feb 2018 (T+90)
97,000 shares@ CA$0.1355.6% of flowCommon SharesTSXSEDI:3082463
Canonical exit: 8 Feb 2018 (T+90)
139,500 shares@ CA$0.137.7% of flowCommon SharesTSXSEDI:3082462
Canonical exit: 8 Feb 2018 (T+90)
25 of 122 declarations
About Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Acerus Pharmaceuticals Corporation, formerly Trimel Pharmaceuticals Corporation, is a pharmaceutical company focused on the development and commercialization of health products for men. It is listed on the Toronto Stock Exchange under the symbol XTSE.
